UK markets closed

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.88-0.35 (-2.65%)
As of 12:23PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
73,622
79,204
86,160
97,074
122,473
Operating expenses
Research development
158,993
163,524
164,522
174,111
136,756
Selling general and administrative
56,709
52,887
45,482
32,536
27,356
Total operating expenses
215,702
216,411
210,004
206,647
164,112
Operating income or loss
-142,080
-137,207
-123,844
-109,573
-41,639
Interest expense
8,589
5,148
0
0
-
Total other income/expenses net
-
-
83
-27
149
Income before tax
-136,004
-130,995
-122,188
-107,579
-35,019
Income tax expense
2,233
2,821
-433
-28,583
1,149
Income from continuing operations
-138,237
-133,816
-121,755
-78,996
-36,168
Net income
-138,237
-133,816
-121,755
-78,996
-36,168
Net income available to common shareholders
-138,237
-133,816
-121,755
-78,996
-36,168
Basic EPS
-2.90
-6.38
-5.91
-3.92
-1.81
Diluted EPS
-2.90
-6.38
-5.91
-3.92
-1.81
Basic average shares
20,026
20,969
20,603
20,171
19,940
Diluted average shares
20,026
20,969
20,603
20,171
19,940